Mohammad Ammad Ud Din

Dr. Mohammad Ammad Ud Din


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2022 in Clinical Lymphoma Myeloma and Leukemia
Verified
Journal Article
Closed access
MDMohammad Ammad Ud Din
Mohammad Ammad Ud Din
STSamarthkumar Thakkar
Samarthkumar Thakkar
HPHarsh Patel
Harsh Patel
HSHassan Saeed
Hassan Saeed
SHSyed Ather Hussain
Syed Ather Hussain
FAFaiz Anwwer
Faiz Anwwer

2 May 2023 in Transplant Infectious Disease
Verified
Journal Article
Closed access
MDMohammad Ammad Ud Din
Mohammad Ammad Ud Din
AJAli Jaan
Ali Jaan
MSMoazzam Shahzad
Moazzam Shahzad
HLHania Liaqat
Hania Liaqat
JMJoseph McGuirk
Joseph McGuirk
MMMuhammad Umair Mushtaq
Muhammad Umair Mushtaq

11 November 2023 in American Journal of Hematology
Verified
Journal Article
Closed access
NNNiraj Neupane
Niraj Neupane
SLSoon K. Low
Soon K. Low
HKHimal Kharel
Himal Kharel
SBSanket Bhattarai
Sanket Bhattarai
STSangharsha Thapa
Sangharsha Thapa
PKPeter Kouides
Peter Kouides

1 April 2022 in Hematology, Transfusion and Cell Therapy
Verified
Journal Article
Open access
MDMohammad Ammad Ud Din
Mohammad Ammad Ud Din
HLHania Liaqat
Hania Liaqat
FAFaiz Anwwer
Faiz Anwwer

24 February 2021 in Clinical Case Reports
Verified
Journal Article
Open access
PDF file
MDMohammad Ammad Ud Din
Mohammad Ammad Ud Din
SHSyed Ather Hussain
Syed Ather Hussain
SJSaad Jamshed
Saad Jamshed
Long‐term use of hydroxyurea can cause leg ulcers which usually do not heal unless the drug is discontinued. Patients should be counseled regarding alternative lines of treatment like anagrelide and pegylated‐interferon.

30 March 2021 in European Journal of Case Reports in Internal Medicine
Verified
Journal Article
Open access
PDF file
MDMohammad Ammad Ud Din
Mohammad Ammad Ud Din
SHSyed Ather Hussain
Syed Ather Hussain
ABAmy Bodrog
Amy Bodrog
Blood dyscrasias associated with levetiracetam use can be difficult to identify, especially when other potential differential diagnoses are concurrently present. Here we present a 57-year-old man with metastatic adenocarcinoma of unknown primary origin on levetiracetam who initially presented with an in-stent thrombosis of the right external iliac vein and then developed worsening thrombocytopenia followed by pancytopenia. Levetiracetam was not identified as the culprit until other causes like platelet consumption, heparin-induced thrombocytopenia, idiopathic immune thrombocytopenic purpura, and bone marrow involvement by metastatic disease were ruled out.